Gases (SF6 and C3F8) and silicone oil are the most commonly used tamponade agents, which provide perfect tamponading effect to the superior half of the retina. These agents are lighter than water and make poor contact with the inferior retina.
The global vitreous tamponades market is estimated to account for US$ 92.3 Mn in terms of value by the end of 2027.
Global Vitreous Tamponades Market: Drivers
Increasing prevalence of age-related macular degeneration (AMD) is expected to propel growth of the global vitreous tamponades market over the forecast period. For instance, according to Bright Focus Foundation, around 11 million people in the U.S. have some form of age-related macular degeneration and the number is expected to double to nearly 22 million by 2050.
Global Vitreous Tamponades Market: Opportunities
R&D in vitreous tamponades is expected to offer lucrative growth opportunities for players in the global vitreous tamponades market. For instance, in June 2018, the study ‘Risk Factors for Retinal Redetachment After Silicone Oil Removal: A Systematic Review and Meta-Analysis’ reported that aphakic eye, high myopia, previous failed retinal surgery, ocular trauma, lack of 360° laser, and scleral encircling band were possible risk factors relating to the occurrence of retinal redetachment after silicone oil removal.
Global Vitreous Tamponades Market: Restraints
Decline in diabetic retinopathy cases in North America is expected to hinder growth of the global vitreous tamponades market. For instance, in June 2018, the study, ‘Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives’, reported that prevalence of diabetic retinopathy in was approximately half that in previous reports for American Indians and Alaska Natives, and prevalence of diabetic macular edema was less than that reported in non- American Indians and Alaska Natives populations.
The global vitreous tamponades market was valued at US$ 76.0 Mn in 2019 and is forecast to reach a value of US$ 92.3 Mn by 2027 at a CAGR of 2.4% between 2020 and 2027. Increasing prevalence of age-related macular degeneration (AMD) is expected to propel growth of the global vitreous tamponades market over the forecast period.
Gases vitreous tamponades segment held dominant position in the global vitreous tamponades market in 2019, accounting for 81.3% share in terms of value, the segment growth is attributed to increasing research and development activity.
Major players in the global vitreous tamponades market are focused on adopting various marketing strategies to enhance their market share. For instance, in September 2019, ZEISS Medical Technology Segment of Carl Zeiss Meditec AG demonstrated new digital and industry first solutions at the European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in Paris.
Major players in the market are also focused on demonstrating compliance to regulatory practices. For instance, in July 2019, Alchimia srl announced that the company’s manufacturing site is U.S. Food and Drug Administration approved.
Global Vitreous Tamponades Market: Competitive Landscape
Major players operating in the global vitreous tamponades market include, Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH.
Global Vitreous Tamponades Market: Key Developments
Major players in the global vitreous tamponades market are focused conducting awareness programs. For instance, in February 2020, Bausch + Lomb collaborated with Prevent Blindness, a volunteer eye health non-profit organization, for the fifth consecutive year to raise awareness of Age-Related Macular Degeneration (AMD), one of the leading causes of vision loss in adults 50 years of age and older.
Scope of the report